SCHEMBL20867306

SCHEMBL20867306

CC(C)(c1nc(C(=N)ON)c(N2CCOCC2)s1)C(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.31
▸ LMNA P02545 1/20 0.30
▸ AOC3 Q16853 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20866838 0.91 ATM (0.32) ATMLMNAAOC3
SCHEMBL24612293 0.85 ATM (0.31) ATMLMNA
SCHEMBL20866960 0.83 ATM (0.32) ATM
SCHEMBL24612210 0.74 FBP1 (0.31) —
SCHEMBL20867295 0.74 — —
SCHEMBL24612188 0.74 PIK3CD (0.30) —
SCHEMBL20866963 0.73 PIK3CD (0.30) —
SCHEMBL20867257 0.71 SYK (0.31) —
SCHEMBL20866762 0.70 PIK3CA (0.30) —
SCHEMBL20867213 0.70 KCNH2 (0.40) ATMAOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback